Discriminant function analysis has been applied to the results of activity and inhibitor measurements carried out on a series of 229 specimens using benzoyicholine and butyrylthiocholine as substrate. The discriminant function was more effective in differentiating cholinesterase genotypes than either a single test or a combination of two tests.
Genetic variants of plasma cholinesterase (acylcholine acylhydrolase, E.C. 3.1.1.8) are phenotyped from their inhibition characteristics with a particular inhibitor and substrate, e.g., fluoride and benzoyicholine. No single inhibitor will differentiate between all the genetic variants, and improved differentiation can be obtained using results obtained with two inhibitors. \ It was reasoned that since discrimination was improved by using results of two tests, further improvement might be obtained if a combination of results from several different inhibitor tests was used. The mathematical technique required for this, known as discriminant function analysis, was first introduced by Fisher, 2 and since that time has been used by several workers to separate patients' data into distinct groupS. 3.4 Two separate stepwise discriminant analyses were performed. The first used the results of activity and inhibitor measurements with a benzoyicholine substrate and the second used results of activity and inhibitor measurements with butyrylthiocholine as substrate. Materials Cholinesterase assays METHOD 1 Cholinesterase activity was measured according to the method of Kalow and Lindsay" using benzoylcholine (50 #Lmol/L) in Sorenson phosphate buffer (67 mmol/L, pH 7·4) as substrate. Inhibitor numbers were determined using the following inhibitors: dibucaine hydrochloride (10 ILmol/L), R02-0683 (10 nmolfL), urea (3 mol/L), succinyl dicholine chloride (1 mmol/L), butan-l-ol (1% v/v; 0·14 mol/L), sodium chloride (0,5 mol/L) sodium bromide (1 mol/L) and sodium fluoride (50 ILmol/L).
METHOD 2
Cholinesterase activity was also determined following the method of Das and Lidde1l 6 using butyrylthiocholine (7·5 mmol/L) as substrate in 5,5'-dithiobis(2-nitrobenzoic acid) (0,26 mmol/ L). Inhibitor numbers were determined using the following inhibitors: dibucaine hydrochloride (100 ILmollL), R02-0683 (10 ILmollL), succinyldicholine chloride (10 mmol/L), butan-1-01 (6% v/v; 0·84 mol/L), and sodium fluoride (50, 100 ILmollL).
Assays using either method were carried out at 25°C and care was taken to avoid preincubation of the inhibitor with plasma, particularly in the case of urea. 7 However for measurement of inhibition by R02-0683 a preincubation of 2 h was required."
STEPWISE DISCRIMINANT ANALYSIS
This was performed using the BMDP statistics package." Results lying outside of 3 SD of the mean for any particular test with the different phenotype groups were not included in the analysis.
Results

QUALITY CONTROL
Results of daily analysis of the control materials fell within 2 SD of the all result mean during the several months of the study, and the assays were judged to be in control. PHENOTYPING 
STEPWISE DISCRIMINANT ANALYSIS
The results of activity measurements and the eight inhibitor numbers were analysed, and the results of the analysis are summarised in Table  2A . The combination of tests which afforded best discrimination were, in order of importance, R02-0683, urea, dibucaine. chloride. and (Table 2A , column b). Since the E~Ef group was readily discriminated from the other groups this was also removed from the discrimination in an attempt to improve discrimination between the four remaining groups, but this was not effective (Table 2A, (Table 3 ).
The best discrimination was obtained using a function which combined a series of five tests and in order of importance these were: R02-0683, fluoride (100 ILmoUL), butan-l-ol, suecinyldicholine, and fluoride (50 ILmoUL) number. Overall the discrimination was no more effective than that based on tests using benzoylcholine as substrate (Table 2B) 'Results for two specimens. and c) did not greatly improve the discrimination.
Discussion
The discriminant analysis has proved more effective than either a single inhibitor test or a combination of two inhibitor tests in differentiating between plasma cholinesterase phenotypes. The discriminant function (i.e., the combination of the results of several inhibitor tests) can be thought of as a multiple probe of the active site of cholinesterase, and only a test of this complexity is likely to differentiate simultaneously between the genetically determined variations in the structure of the site. The major problem with discriminations based on results of tests obtained with either substrate was the difficulty in separating E~E{ from E~E~. Segregation of these genotypes is a well-known problem. The discriminant analysis may be detecting subtle differences between cholinesterases from different subjects undetectable by the dibucaine and fluoride numbers used to assign the genotypes, and the genotype should be further subdivided based on the results of the more complex discriminant analysis, unless the genotype is confirmed by family studies.
In a previous study, I the best discrimination between genotypes was obtained using the combination of fluoride number and pancuronium dibutyryloxy number. The latter inhibitor is not readily available and therefore was not investigated in this study.
Conclusion
Discriminant analysis based on enzyme activity and inhibitor numbers using two different substrates has provided an improved discrimination of cholinesterase genotypes compared with that obtained with either a single test or a combination of two tests. A single inhibitor which will differentiate all genotypes may not exist. Discriminant analysis of combinations of activity and inhibitor numbers could provide a viable specialised method for identifying both the common and rarer genotypes.
